BF
ABBV icon

Brogan Financial’s AbbVie ABBV Stock Holding History

Brogan Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$671K Sell
3,083
-29
-0.9% -$6.43K 0.29% 21
2025
Q4 		$711K Buy
3,112
+22
+0.7% +$5.01K 0.31% 17
2025
Q3 		$715K Buy
3,090
+74
+2% +$15.1K 0.3% 16
2025
Q2 		$560K Sell
3,016
-182
-6% -$33.8K 0.25% 23
2025
Q1 		$670K Buy
3,198
+234
+8% +$45.5K 0.33% 18
2024
Q4 		$527K Buy
2,964
+28
+1% +$5.15K 0.26% 21
2024
Q3 		$580K Buy
2,936
+23
+0.8% +$4.29K 0.33% 21
2024
Q2 		$500K Buy
2,913
+27
+0.9% +$4.47K 0.31% 21
2024
Q1 		$526K Sell
2,886
-887
-24% -$153K 0.35% 20
2023
Q4 		$585K Buy
3,773
+40
+1% +$5.83K 0.43% 16
2023
Q3 		$556K Hold
3,733
– – 0.49% 15
2023
Q2 		$503K Hold
3,733
– – 0.43% 15
2023
Q1 		$595K Hold
3,733
– – 0.51% 14
2022
Q4 		$603K Buy
+3,733
New +$572K 0.54% 14

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brogan Financial's ABBV Position: Q1 2026 in Review

Brogan Financial reduced its AbbVie (ABBV) stake by 0.93% in Q1 2026, selling an estimated $6.43K and leaving 3,083 shares worth $671K. The position accounts for 0.29% of the portfolio, ranked #21.

Brogan Financial first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $715K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Brogan Financial held 3,083 shares of AbbVie worth $671K as of Q1 2026.
  • Brogan Financial sold 29 AbbVie shares in Q1 2026, an estimated $6.43K.
  • AbbVie made up 0.29% of Brogan Financial's portfolio in Q1 2026, its #21 holding.
  • Brogan Financial first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • Brogan Financial's AbbVie position peaked at $715K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Brogan Financial's 13F filing for Q1 2026, filed 11 May 2026.